← Back to Clinical Trials
Recruiting NCT06558487

The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model

Trial Parameters

Condition Oncology
Sponsor Erasmus Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-12-02
Completion 2025-12-01
Interventions
Cancer Admission Score Prediction Model

Brief Summary

The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.

Eligibility Criteria

Inclusion Criteria: * Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months. * Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit. Exclusion Criteria: * \<18 years old * Only received a surgical intervention as cancer treatment * Admitted to the ED for the surgical department

Related Trials